Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01147978
Other study ID # K070101
Secondary ID ID RCB / 2007-A0
Status Completed
Phase N/A
First received June 18, 2010
Last updated April 22, 2014
Start date April 2009
Est. completion date November 2012

Study information

Verified date April 2014
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Interventional

Clinical Trial Summary

The investigators propose an interventional multicentric (23 ICUs) study measuring the impact of a consultation at the end of ICU stay for the patients and his/her families on the prevalence of symptoms of PTSD and anxiety or depression 3 months and one year after discharge. Patients will be randomly assigned to a intervention or control group. In the intervention group, the patient and his/her family will benefit from an conference by the intensivist at the end of the ICU stay, regarding information about the progress of his stay in ICU, his orientation after discharge, the possibility of consulting a GP, etc. Patients and proxies will be interviewed by phone three months and one year after discharge from ICU. Main instruments are Hospital Anxiety and Depression Scale, and Impact of Events Scale Revised.


Description:

There are many risk factors of stress for a patient during a stay in Intensive care unit. This stress can be responsible for psychiatric symptoms hindering seriously the quality of life of the patient in the months following discharge from ICU. Survivors of ICU suffer from traumatic memories (nightmares, acute anxiety), who can be associated to post traumatic stress disorder (PTSD) or of anxious and depressive symptoms. Prevalence of PTSD in the months following ICU stay is estimated between 14 and 41 %, that of the symptoms of anxiety between 12 % and 47 %, and that of the symptoms of depression between 10 % and 30 %. Recent studies showed that these symptoms could concern several thousand patients every year in France.

We propose an interventional multicentric (23 ICUs) study measuring the impact of a consultation at the end of ICU stay for the patients and his/her families on the prevalence of symptoms of PTSD and anxiety or depression 3 months and one year after discharge.

Patients will be randomly assigned to a intervention or control group. In the intervention group, the patient and his/her family will benefit from an conference by the intensivist at the end of the ICU stay, regarding information about the progress of his stay in ICU, his orientation after discharge, the possibility of consulting a general practitioner (GP), etc. The family, if present, will be invited to attend the conference. In the control group, patients will be cared in a usual way (without end of stay conference) as it is made in all the intensive care units in France. Inclusion criteria are 1) patient alive at the end of ICU stay, 2) Age > 18 years, 3) more than 48 hours of mechanical ventilation 4) accepting to be called back 3-month and on one year after discharge of ICU. Exclusion criteria are 1) Chronic cognitive deterioration before ICU admission, 2) inclusion in another interventional randomized essay 3) non French-speaking patients, 4) impossibility to agree 5) End of life situation (survival at 3 months very improbable), 6) deaf-dumb patients. Patients and proxies will be interviewed by phone three months and one year after discharge from ICU. Main instruments are Hospital Anxiety and Depression Scale, and Impact of Events Scale Revised. Number of patients to include takes into account an estimated prevalence of PTSD of 20 %, and the impact expected from the intervention is to obtain 10 % of PTSD in the intervention group. With a beta power of 90 % and a risk of 5 %, number of patients needed three months after discharge is 438 (219 in every group), i.e 525 patients (263 in every arm because of the late deaths and lost sight). This study should supply updated and relevant data on prevalence and risk factors of symptoms of PTSD and Anxiety-depression three months and one year after discharge from ICU. Furthermore, we propose an intervention that could demonstrate that a brief and easily reproducible communication strategy could significantly reduce prevalence of PTSD and anxiety-depression for patients and their families after discharge from ICU


Recruitment information / eligibility

Status Completed
Enrollment 303
Est. completion date November 2012
Est. primary completion date August 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patient alive at the end of ICU stay

- age > 18 years

- more than 48 hours of mechanical ventilation

- accepting to be called back 3-month and on one year after discharge of ICU.

Exclusion Criteria:

- chronic cognitive deterioration before ICU admission

- inclusion in another interventional randomized essay

- non French-speaking patients

- impossibility to agree for participation

- end of life situation (survival at 3 months very improbable)

- deaf-dumb patients.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
End of ICU stay conference
Conference with patient and proxies, senior physician and nurse regarding the ICU stay and the orientation of the patient

Locations

Country Name City State
France Medical ICU Paris

Sponsors (3)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris Institut National de la Santé Et de la Recherche Médicale, France, University Paris 7 - Denis Diderot

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Symptoms of PTSD in ICU patients three months after discharge from ICU No
Secondary Symptoms of PTSD, anxiety, and depression in ICU patients three months after discharge from ICU No
Secondary Symptoms of PTSD, anxiety, and depression in ICU patients one year after discharge from ICU No
Secondary Symptoms of PTSD, anxiety, and depression in families three months after discharge from ICU No
Secondary Symptoms of PTSD, anxiety, and depression in families one year after discharge from ICU No
See also
  Status Clinical Trial Phase
Recruiting NCT04045366 - Impact of Capillary Leak and Hypoalbuminemia on PK/PD of Anidulafungin and Caspofungin in Critically Ill Patients
Completed NCT01411553 - ECG Leadwires: Disposable Versus Cleaned, Reusable N/A
Completed NCT00288743 - Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study Phase 2
Recruiting NCT03529617 - Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates
Not yet recruiting NCT05564975 - Construction and Application of Pressure Injury Risk Prediction Model for Critically Ill Patients
Recruiting NCT06234787 - Continuous Subcutaneous Glucose Monitoring in Critical Patients
Completed NCT02198950 - Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis
Recruiting NCT01317381 - ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill Phase 4
Completed NCT00470821 - Oral Melatonin in Critically Ill High-risk Patients Phase 4
Completed NCT00460252 - Tight Glycemic Control by eMPC Algorithm in Medical ICU Patients. N/A
Recruiting NCT06049979 - Correlation Between Intestinal Blood Flow and Intestinal Dysfunction in Critically Ill Patients
Active, not recruiting NCT04793568 - Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study Phase 2
Recruiting NCT05458687 - Traditional Chinese Medicine for Complications in Critically Ill Patients N/A
Completed NCT01963013 - Non-returning Catheter Valve for Reducing CAUTI N/A
Completed NCT01794468 - A New Monitor to Measure Dermal Blood Flow in Critically Ill Patients: a Preliminary Study N/A
Completed NCT03469882 - High Protein Intake and Early Exercise in Adult Intensive Care Patients N/A
Recruiting NCT04962204 - Virtual Visitation in Intensive Care Unit Study N/A
Completed NCT03205592 - Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients
Recruiting NCT01995565 - Regional Cerebral Hemodynamics Related to Global Hemodynamics N/A
Completed NCT00143494 - The Estimation of Abdominal Pressure by the Bladder and Gastric Pressure N/A